At a glance
This program funds advanced translational research in Duchenne muscular dystrophy to move promising ideas toward clinical use, and applications must address at least one listed focus area. U.S. Department of War organizations, including foreign and domestic, for-profit and nonprofit, and public or private entities, may apply; independent investigators may serve as principal investigator. The program expects to fund about 6 awards with roughly $8.46 million total, with cost caps ranging from $0.91 million to $1.9 million depending on funding level and whether there is one PI or a partnering PI option. Cost sharing is not required. Awards are limited to grants, with no geographic restriction stated, and applications involving painful research on domestic cats or dogs are not supported except for studies relating to military or service animals.
What it funds
Official description from grants.gov
Summary: The fiscal year 2026 (FY26) Duchenne Muscular Dystrophy Research Program (DMDRP) Clinical/Translational Research Award (CTRA) supports advanced translational research to accelerate promising ideas in Duchenne muscular dystrophy (DMD) research toward clinical applications. Research must address at least one of the FY26 CTRA Focus Areas. Research projects investigating therapies that will be efficacious across the life span are strongly encouraged. Distinctive Features: The FY26 CTRA offers two funding levels: • Funding Level 1 to support smaller, less complex preclinical and/or clinical research. • Funding Level 2 to support larger, more complex preclinical and/or clinical research. The FY26 CTRA also offers a Partnering PI Option (PPIO) to support meaningful and productive partnerships between two investigators collaborating on the proposed research project. The PPIO has two eligibility categories: • Early-Career Partnering PI category for an independent, early-career investigator within 10 years of their first faculty appointment (or equivalent) by the time of application submission. • Established Interdisciplinary Partnering PI for independent investigators at all academic levels, or equivalent, in an area other than muscular dystrophy, seeking to transition to a career in DMD, thereby bringing their expertise to the field. Preliminary data are required for all applications. Pilot clinical trials and clinical trial readiness studies to better inform development of drugs, devices, and other interventions are allowed.
Who can apply
- Unrestricted
Change history
- Jul 11, 2026 Title updated